ESTRACE® is the only oral, 17β-estradiol therapy indicated for symptomatic relief of menopausal symptoms in Canada.  
Natesto™ is the first and only nasal testosterone replacement therapy approved by FDA and launched in the U.S. for the treatment of male hypogonadism, or "Low T”.
Tefina™, is a “use as required” nasal testosterone gel treatment in development for acquired female anorgasmia.
TriVair Device
TriVair™ is an award-winning single-use unit-dose dry powder inhalation drug delivery platform with applications for both nasal and pulmonary dosing
Trimel is a specialty pharmaceutical company involved in the sales, distribution and development of Men's Health, Women's Health and Respiratory Medicines.
© 2015 by Trimel Pharmaceuticals Corporation